ArticleUrologic oncology2026

Comparative effectiveness of intravesical gemcitabine vs. sequential gemcitabine and docetaxel for high-risk nonmuscle-invasive bladder cancer.

Jacob A Moyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.